ASCO 2012 Report – Combination Lenalidomide (Revlimid)/ Rituximab (Rituxan) improves response rate in patients with relapsed follicular lymphoma
by Bruce Sylvester – Investigators reported at ASCO that relapsed follicular lymphoma patinets treated with combination lenalidomide (Revlimid) and rituximab (Rituxan) achieved a higher percentage of overall response… read more.

